Clinical Trial

Incidence, Associated Factors, and Burden of Post COVID-19 Condition in Brazil

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 19, 2025 (before its estimated July 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
This is a national retrospective cohort study with internet-based recruitment which intends to enroll 1,694 adult patients with COVID-19 diagnosis during the SARS-CoV-2 omicron wave in Brazil. Participants with confirmed symptomatic COVID-19 after january 2022 will be evaluated in order to assess incidence, potential risk factors and impact of post COVID-19 condition according to the WHO definition on health-related quality of life and other relevant patient-centered outcomes.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-04-18; most recent amendment 2025-02-17.
Status change: Not Yet Recruiting → Recruiting 2023-07-30
Trial Details
NCT Number NCT05822193
Lead Sponsor Inova Medical
Collaborators: Merck Sharp & Dohme LLC
Conditions Post-Acute COVID-19 Syndrome
Enrollment 1,694 participants
Start Date 2023-07-21
Primary Completion 2025-07-01 (estimated)
Study Completion 2025-07-31 (estimated)
Updated on ClinicalTrials.gov 2025-02-19